Category: Press releases

Proposed changes to EMA’s access to documents policy fall short on proactive disclosure (May 2017)

May 1, 2017 Press releases, Publications

Brussels, 18 May 2017 In a joint response to the EMA's consultation on its policy on access to documents, Health Action International, the International Society of Drug Bulletins, NoGracias, the Nordic Cochrane Centre and Prescrire called for a comprehensive public register of all the documents the EMA produces and receives. The coalition also strongly encourages the EMA to increase resources so it can more efficiently handle access requests to documents.

Health technology assessment: Joint response to the EU Commission Consultation (January 2017)

January 1, 2017 Press releases, Publications

Paris, 13 January 2017 In a joint response to the EU Commission Consultation on health technology assessment, Prescrire, the International Socety of Drug Bulletins and the Medicines in Europe Forum argue in favour of transparency, independence and high-quality evidentiary standards.

Open letter to the European Commission on “Strengthening the Balance in the Pharmaceutical Systems in the EU and its Member States” (September 2016)

September 1, 2016 Press releases, Publications

13 September 2016 36 Civil Society Organisations have sent an Open letter to the European Commission urging the follow-up of the June 2016 EU Council Conclusions on "Strengthening the Balance in the Pharmaceutical Systems in the EU and its Member States »

EMA’s report on adaptive pathways: little data and much ado about nothing

August 31, 2016 Press releases, Publications

A joint press release issued by ISDB, MiEF and Nordic Cochrane Centre regarding the recently published report on EMA's controversial "adaptive pathways" pilot project. The report includes no new factual data, with no information shared about the drug's indications, type of clinical trial data to be submitted or which patient representatives were consulted. Read more…

EMA’s report on adaptive pathways: little data and much ado about nothing (August 2016)

August 1, 2016 Press releases, Publications

Brussels, 31 August 2016 In a joint press release, the International Society of Drug Bulletins, the Medicines in Europe Forum and the Nordic Cochrane Centre observe that EMA's report on "adaptive pathways" delivers little factual data but seems to indicate disappointing results for the controversial pilot project.

International Society of Drug Bulletins

Category: Press releases

Proposed changes to EMA’s access to documents policy fall short on proactive disclosure (May 2017)

Health technology assessment: Joint response to the EU Commission Consultation (January 2017)

Open letter to the European Commission on “Strengthening the Balance in the Pharmaceutical Systems in the EU and its Member States” (September 2016)

EMA’s report on adaptive pathways: little data and much ado about nothing

EMA’s report on adaptive pathways: little data and much ado about nothing (August 2016)

Recent Publications

Newsletter

Sign up for our newsletter

Recent Campaigns